D
Derek P. Chew
Researcher at Flinders University
Publications - 393
Citations - 21169
Derek P. Chew is an academic researcher from Flinders University. The author has contributed to research in topics: Myocardial infarction & Acute coronary syndrome. The author has an hindex of 60, co-authored 342 publications receiving 18879 citations. Previous affiliations of Derek P. Chew include Flinders Medical Centre & Auckland City Hospital.
Papers
More filters
Journal ArticleDOI
Core Outcome Measures for Trials in People With Coronavirus Disease 2019: Respiratory Failure, Multiorgan Failure, Shortness of Breath, and Recovery.
Allison Tong,Amanda Baumgart,Nicole Evangelidis,Andrea K. Viecelli,Simon A. Carter,Luciano Cesar Pontes Azevedo,Tess E Cooper,Andrew D. Bersten,Lilia Cervantes,Derek P. Chew,Sally Crowe,Ivor S. Douglas,Ivor S. Douglas,Ella Flemyng,Julian H Elliott,Elyssa Hannan,Peter Horby,Peter Horby,Martin Howell,Martin Howell,Angela Ju,Angela Ju,Jaehee Lee,Eduardo Lorca,Eduardo Lorca,Deena Lynch,Deena Lynch,Karine E. Manera,Karine E. Manera,John C. Marshall,Andrea Matus Gonzalez,Anne McKenzie,Sangeeta Mehta,Mervyn Mer,Andrew Conway Morris,Dale M. Needham,Saad Nseir,Pedro Póvoa,Mark Reid,Yasser Sakr,Ning Shen,Alan R Smyth,A. John Simpson,Tom Snelling,Tom Snelling,Giovanni F.M. Strippoli,Armando Teixeira-Pinto,Antoni Torres,Antoni Torres,Tari Turner,Steve Webb,Paula R Williamson,Paula R Williamson,Laila Woc-Colburn,Junhua Zhang,Jonathan C. Craig +55 more
TL;DR: In this paper, three online consensus workshops were convened to establish outcome measures for the four core domains of respiratory failure, multiple organ failure, shortness of breath, recovery, and mortality.
Journal ArticleDOI
Guía ESC 2015 sobre el tratamiento de los síndromes coronarios agudos en pacientes sin elevación persistente del segmento ST: Grupo de Trabajo de la Sociedad Europea de Cardiología (ESC) para el tratamiento de los síndromes coronarios agudos en pacientes sin elevación persistente del segmento ST
Marco Roffi,Carlo Patrono,Jean-Philippe Collet,Christian Mueller,Marco Valgimigli,Felicita Andreotti,Jeroen J. Bax,Michael A. Borger,C Brotons,Derek P. Chew,Baris Gencer,Gerd Hasenfuss,Keld Kjeldsen,Patrizio Lancellotti,Ulf Landmesser,Julinda Mehilli,Debabrata Mukherjee,Robert F. Storey,Stephan Windecker,Helmut Baumgartner,Oliver Gaemperli,Stephan Achenbach,Stefan Agewall,Lina Badimon,Colin Baigent,Héctor Bueno,Raffaele Bugiardini,Scipione Carerj,Filip Casselman,Thomas Cuisset,Çetin Erol,Donna Fitzsimons,Martin Halle,Christian W. Hamm,David Hildick-Smith,Kurt Huber,Efstathios Iliodromitis,Stefan James,Basil S. Lewis,Gregory Y.H. Lip,Massimo F Piepoli,Dimitrios J. Richter,Thomas Rosemann,Udo Sechtem,Ph. Gabriel Steg,Christian Vrints,José Luis Zamorano +46 more
TL;DR: Aguilar et al. as discussed by the authors present a Guia de Practica Clinica de the Sociedad Europea de Cardiologia (ESC) that recoge the opinion of the ESC and se ha elaborado tras el estudio minucioso de los datos and la evidencia disponibles hasta la fecha.
Journal ArticleDOI
Rewarming Temperature During Cardiopulmonary Bypass and Acute Kidney Injury: A Multicenter Analysis
Richard F. Newland,Richard F. Newland,Robert A. Baker,Robert A. Baker,Annette L Mazzone,Steven S. Quinn,Derek P. Chew,Derek P. Chew +7 more
TL;DR: Avoidance of hyperthermic perfusion may be more beneficial in reducing AKI than avoidance of rewarming, and this study aimed to evaluate the role of CPB rewarming temperatures on AKI.
Journal ArticleDOI
Randomized Comparison of High-Sensitivity Troponin Reporting in Undifferentiated Chest Pain Assessment
Derek P. Chew,Christopher Zeitz,Christopher Zeitz,Matthew I. Worthley,Matthew I. Worthley,Hugh Grantham,John F. Beltrame,John F. Beltrame,Margaret Arstall,Penelope Coates,Carolyn Astley,Carolyn Astley,Stephen Quinn,Julie Ratcliffe,Matthew Horsfall,Philip G. Aylward +15 more
TL;DR: Clinical effectiveness in the adoption of high-sensitivity troponin may require close coupling with protocols that guide interpretation and care, and the hs-reporting alone is associated with only modest changes in practice.
Journal ArticleDOI
Bivalirudin vs Heparin in Percutaneous Coronary Intervention: A Pooled Analysis:
Ramin Ebrahimi,A. Michael Lincoff,John A. Bittl,Derek P. Chew,Kathy Wolski,Nitin Wadhan,Edward J. Toggart,Eric J. Topol +7 more
TL;DR: This analysis further supports the superiority of bivalirudin compared with heparin, providing excellent ischemic protection with a significant reduction of bleeding complications, even in high-risk subgroups.